Literature DB >> 5511573

Regulation of antibody formation by serum antibody. II. Removal of specific antibody by means of exchange transfusion.

J C Bystryn, M W Graf, J W Uhr.   

Abstract

Rabbits were immunized to two antigens and 18-55 days later exchange transfusion was performed using blood of rabbits immunized to one antigen only. By this means, serum antibody levels to one antigen were reduced 50-84% while maintaining serum antibody levels to the second antigen. After exchange, serum antibody levels of the removed antibody rose rapidly for 24-48 hr and then more slowly, reaching peak titers an average of 8 days later. The peak titer was 48-222% higher than the preexchange titer. The specificity of this rebound excluded as a cause nonspecific changes in Ig levels. Passive administration of antibody to a third antigen 4-7 days before the exchange indicated that re-equilibration of preformed antibody was not a major factor in the rebound. A change in the ratio of IgM to IgG antibodies as a cause of an increased neutralization titer in the postexchange sera was also excluded. It was therefore suggested that a change in the rate of antibody formation had occurred, although other changes in the quality of serum antibody were not excluded.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5511573      PMCID: PMC2180498          DOI: 10.1084/jem.132.6.1279

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  THE FORMATION AND PROPERTIES OF POLIOVIRUS NEUTRALIZING ANTIBODY. 5. CHANGES IN THE QUALITY OF 19S AND 7S RABBIT ANTIBODIES FOLLOWING IMMUNIZATION.

Authors:  S E SVEHAG
Journal:  Acta Pathol Microbiol Scand       Date:  1965

2.  A quantitative immunochemical measure of the primary interaction between I BSA and antibody.

Authors:  R S FARR
Journal:  J Infect Dis       Date:  1958 Nov-Dec       Impact factor: 5.226

3.  Human plasmapheresis and its effect on antibodies.

Authors:  J SMOLENS; J STOKES; A B VOGT
Journal:  J Immunol       Date:  1957-11       Impact factor: 5.422

4.  The development of the phage-inactivating properties of serum during the course of specific immunization of an animal: reversible and irreversible inactivation.

Authors:  N K JERNE; P AVEGNO
Journal:  J Immunol       Date:  1956-03       Impact factor: 5.422

5.  The dynamic equilibrium between circulating and extravascular plasma proteins.

Authors:  D GITLIN; C A JANEWAY
Journal:  Science       Date:  1953-09-11       Impact factor: 47.728

6.  ON THE DIFFERENT MOLECULAR FORMS OF ANTIBODY SYNTHESIZED BY RABBITS DURING THE EARLY RESPONSE TO A SINGLE INJECTION OF PROTEIN AND CELLULAR ANTIGENS.

Authors:  D C Bauer; A B Stavitsky
Journal:  Proc Natl Acad Sci U S A       Date:  1961-10       Impact factor: 11.205

7.  The influence of IgM antibody on the neutralisation of T4r bacteriophage by IgG antibody.

Authors:  K J Turner; V Krishnapillai
Journal:  Immunochemistry       Date:  1968-01

8.  A mathematical and experimental study of the kinetics of neutralization of bacteriophage phi chi 174 by antibodies.

Authors:  W M Krummel; J W Uhr
Journal:  J Immunol       Date:  1969-03       Impact factor: 5.422

9.  Antibody formation. V. The avidity of gamma-M and gamma-G guinea pig antibodies to bacteriophage phi-x 174.

Authors:  M S Finkelstein; J W Uhr
Journal:  J Immunol       Date:  1966-11       Impact factor: 5.422

10.  Regulation of antibody formation by serum antibody. I. Removal of specific antibody by means of immunoadsorption.

Authors:  M W Graf; J W Uhr
Journal:  J Exp Med       Date:  1969-11-01       Impact factor: 14.307

  10 in total
  28 in total

1.  Treatment of Goodpasture syndrome with cyclophosphamide, prednisone and plasma exchange transfusions.

Authors:  R D Rossen; J Duffy; K B McCredie; M A Reisberg; J T Sharp; E M Hersh; G Eknoyan; W N Suki
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

2.  Maternally transferred anti-factor VIII IgG reduce the anti-factor VIII humoral immune response in factor VIII-deficient mice.

Authors:  Yann Meslier; Sébastien André; Maud Teyssandier; Srinivas V Kaveri; Sébastien Lacroix-Desmazes
Journal:  Immunology       Date:  2010-12       Impact factor: 7.397

3.  Prolonged antigen half-life in the lymphoid follicles of specifically immunized mice.

Authors:  J G Tew; T E Mandel
Journal:  Immunology       Date:  1979-05       Impact factor: 7.397

4.  A cyclical appearance of antibody-producing cells after a single injection of serum protein antigen.

Authors:  C G Romball; W O Weigle
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

5.  The level and distribution of antibody in syngeneic and allogeneic mated pregnant mice pre-immunized with H-2 alloantigens.

Authors:  G M Taylor
Journal:  Immunology       Date:  1973-11       Impact factor: 7.397

6.  Progress in endocrine exophthalmos.

Authors:  C W Havard
Journal:  Br Med J       Date:  1979-04-14

7.  Suitable hollow fibre immunobioreactors for specific ex vivo removal of antibodies and antigens from plasma.

Authors:  C Larue; V Gueraud; C Rivat
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

8.  Sepcific removal of in vivo antibody by extracorporeal circulation over an immunoadsorbent in gel.

Authors:  I Schenkein; J C Bystryn; J W Uhr
Journal:  J Clin Invest       Date:  1971-09       Impact factor: 14.808

9.  Plasmapheresis combined with lymphocytapheresis and cytotoxic drugs as a therapeutic modality in neuroimmunological diseases.

Authors:  M Valbonesi; F Montani; G Florio; D Zerbi; A Beltramelli
Journal:  Ital J Neurol Sci       Date:  1984-03

10.  Plasma exchange and immunosuppressive drug treatment in myasthenia gravis: no evidence for synergy.

Authors:  C J Hawkey; J Newsom-Davis; A Vincent
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-06       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.